Kelly Mahar Population pharmacokinetics of daprodustat across five phase 2b/3 studies in chronic kidney disease (CKD) patients with anemia
|
Kelly Mahar Innovative adaptive dose simulations in NONMEM to allow simulation-based model evaluation of titration-based dosing, applied to a population dose-hemoglobin model for daprodustat
|
Kelly Mahar Population dose-Hgb modelling of daprodustat across five phase 3 studies in chronic kidney disease (CKD) patients with anemia
|